Crossmark

A Systematic Literature Review and Network Meta-analysis of Azilsartan Medoxomil Compared to Other Anti-hypertensives Efficacy in Lowering Blood Pressure Amongst Mild to Moderate Hypertensive Patients

Crossref DOI link: https://doi.org/10.1007/s12325-024-02997-5

Published Online: 2024-10-16

Published Print: 2024-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Qian, Juying https://orcid.org/0000-0002-7512-3692
Zhang, Mengjun

Chen, Zhangwei
Funding

Funding for this research was provided by:

Hasten Biopharmaceutical Co.,Ltd
License Information

Text and Data Mining valid from 2024-10-16

Version of Record valid from 2024-10-16
More Information

Article History

Received: 30 June 2024

Accepted: 11 September 2024

First Online: 16 October 2024

Declarations

:

: Mengjun Zhang is a full-time employee of Hasten Biopharmaceutical Co., Ltd. Juying Qian and Zhangwei Chen declared no conflict of interest.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.

Document is current

Any future updates will be listed below